Breaking News on Global Pharmaceutical Technology & Manufacturing

Delivery formulations

News headlines

Telephus gets patents for superbug battling antibodies

12-Feb-2016 - Australia has granted Telephus Medical a patent for an antibody that targets superbugs, including MRSA.

Catalent Q2: Softgel growth blighted by Beinheim plant suspension

10-Feb-2016 - Suspension of operations at a French softgel facility reduced Catalent’s second quarter revenues by around $21m, but the firm expects full production to restart in March.

GSK is latest to assess VBI Vaccines' biologic stability tech after Sanofi

10-Feb-2016 - GSK will test a stability enhancement technology developed by VBI Vaccines in a deal announced this week.

AstraZeneca: China formulated anaemia drug on fast-track, but timeframes vague

09-Feb-2016 - AstraZeneca has reformulated roxadustat using materials sourced in China to make it eligible for fast track review through the country's new "green pass" process.

Juniper to reformulate unpleasant tasting PharmAust cancer drug

08-Feb-2016 - Up to 90% of new chemical entities having properties that make them a challenge to successfully formulate, says Juniper Pharmaceuticals which has won a reformulation and manufacturing contract from PharmAust.

Sandoz teams with delivery tech firm MedinCell to get under the skin of cancer

04-Feb-2016 - Novartis subsidiary Sandoz will commercialise small and large molecule injectables using French delivery tech firm MedinCell’s subcutaneous controlled release platform.

MannKind sheds light on new $100m inhaled formulation partner

04-Feb-2016 - MannKind has spoken about Receptor Life Science, a newly-formed company which last month licensed the Technosphere inhaled delivery platform from the struggling firm.

Regulatory reforms to reshape drug manufacturing in China says expert

28-Jan-2016 - More plants in China will close says a US-based analyst who predicts that some drugmakers' inability to comply with stricter quality rules will create an opportunity for those that can.

Could drug-loaded dental implants offer pain-free chronic med delivery?

27-Jan-2016 - Drug-loaded dental implants which release payload on-demand could alleviate invasive procedures associated with chronic diseases, scientists suggest.

Increased US FDA oversight driving recent China plant warnings

27-Jan-2016 - The recent tide of Warning Letters issued to Chinese API and finished formulation makers reflects an increase in regulatory oversight, the US FDA says.

Catalent continues to scout acquisitions and licensing in 2016

25-Jan-2016 - Catalent will pursue strategic acquisitions and licensing in 2016, said VP Marketing & Strategy Elliott Berger, noting growth areas include complex delivery technologies and specialised logistics.

$4m grant not to be sniffed at as Mucosis looks to advance intranasal RSV vaccine

21-Jan-2016 - Mucosis has been awarded a Wellcome Trust grant of €3.7m ($4m) to help develop a Respiratory Syncytial Virus (RSV) vaccine using its intranasal delivery platform.

New Novozymes subsidiary Albumedix to develop its own drug pipeline says CEO

20-Jan-2016 - Novozymes’ new subsidiary Albumedix has announced its intention to develop biobetters and says the first candidate could be in Phase I trials by 2019.

Novozymes says pharma won't drive growth and sets up albumin subsidiary

20-Jan-2016 - Novozymes has launched its albumin operations as a stand-alone subsidiary and reiterated that its pharma business is no longer a growth driver.

Mylan: GMP issues and production halt at Agila aseptic plant 'not material'

20-Jan-2016 - Mylan has stopped production at a sterile injectables plant after Polish regulators observed 29 major violations of GMP, an EU statement of non-compliance reveals.

Colorcon sweetens its offering with Paulaur's pharma sugar sphere biz

19-Jan-2016 - Colorcon has acquired Paulaur Corporation’s sugar sphere business to help feed pharma’s demand for multiparticulate dosage forms.

Centauri buys nucleotide tech to develop alternatives to antibiotics

18-Jan-2016 - UK-based biotech Centauri Therapeutics has acquired a “programmable immunity” aptamer technology from Altermune Technologies.

Allergan buys toxin delivery tech firm, boosts Botox portfolio

11-Jan-2016 - Allergan has acquired neurotoxin company Anterios for $90m (€83m).

Fresenius Kabi moves into prefilled syringe space through BD Rx buy

11-Jan-2016 - Fresenius Kabi has moved into the prefilled syringe space by acquiring Becton, Dickinson and Company’s injectables business and US manufacturing plant.

Sanofi’s ‘conflicted’ handling of Afrezza stunted inhaled insulin R&D, says Dance CEO

07-Jan-2016 - Despite Sanofi’s “conflicted” management and subsequent abandonment of Afrezza, the market opportunity for inhaled insulin is still huge, according to Dance Biopharm's CEO.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...

Product Innovation